Business
Novartis AG Enterprise Technology Report 2025: Digital Transformation Strategies, Innovation Programs, Technology Initiatives, Partnerships, Investment & Acquisition, Network Map
Novartis presents key market opportunities through its focus on digital transformation, innovation programs, and strategic tech initiatives. It leverages partnerships, product launches, investments, and acquisitions to enhance its presence across therapeutic areas like oncology and immunology.Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Novartis AG 2025" has been added to ResearchAndMarkets.com's offering. The report delves into comprehensive details of Novart
About this update from Novartis Ag
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Novartis presents key market opportunities through its focus on digital transformation, innovation programs, and strategic tech initiatives. It leverages partnerships, product launches, investments, and acquisitions to enhance its presence across therapeutic areas like oncology and immunology.","length":294,"tagName":"p"},{"type":"text","content":"Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Novartis AG 2025" has been added to ResearchAndMarkets.com's offering.","length":166,"tagName":"p"},{"type":"text","content":"The report delves into comprehensive details of Novartis's digital strategies and innovation initiatives. Highlighted are insights into their digital transformation programs that encompass technology initiatives, including partnerships, product launches, and strategic acquisitions. Key technology themes, objectives, and potential benefits are also explored.","length":363,"tagName":"p"},{"type":"text","content":"Novartis AG, a global pharmaceutical leader, spearheads innovation in the realm of healthcare with its robust research and development initiatives. Specializing in therapeutic areas such as cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, neuroscience, and oncology, Novartis is dedicated to providing advanced medicinal solutions. The company's expansive product lineup includes well-known brands like Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, which are essential in advancing health outcomes worldwide.","length":546,"tagName":"p"},{"type":"text","content":"Novartis extends its reach through a wide range of customers including pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, and pharmacy benefit managers. Its global manufacturing footprint span...